Ticarcillin/clavulanate for the treatment of serious infections in hospitalized pediatric patients.
Blumer
J L
JL
Rainbow Babies and Children's Hospital and the Department of Pediatrics and Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-6010, USA.
D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000009:adverse effects; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011379:Prognosis; D012720:Severity of Illness Index; D013982:Ticarcillin / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D002969:Clavulanic Acids; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin